Psychedelic Medical Start-Up AWAKN Life Sciences Enters the UK Market with Dr. Ben Sessa Post published:June 18, 2020 Post category:Press Release
Mira X Acquisition Corp. Announces Termination of Proposed Qualifying Transaction with Field Trip Psychedelics Inc. Post published:June 18, 2020 Post category:Press Release
Wuhan General Group Announces Name Change and Rebranding to M2Bio Sciences Post published:June 18, 2020 Post category:Press Release
MindMed To Evaluate Ayahuasca’s Active Ingredient DMT In Phase 1 Clinical Trial Collaboration Post published:June 18, 2020 Post category:Press Release
NeonMind Files Patent Application for Therapeutic Use of DMT Post published:June 18, 2020 Post category:Press Release
Interview with GreenStar Biosciences and Eleusian Biosciences, Following Acquisition Announcement Post published:June 17, 2020 Post category:Interview
Mydecine Innovations Group Signs Definitive Agreement to Acquire Mindleap Health’s Advanced Digital Telehealth Platform Post published:June 17, 2020 Post category:Press Release
Yukoterre Resources Announces Proposed Reverse Takeover by Psychedelics Company Silo Wellness Post published:June 17, 2020 Post category:Press Release